PubMed COVID-19 Clinical Care

New-Onset Psoriatic Arthritis Following COVID-19 mRNA Vaccination in a Psoriatic Patient Under Anti-tumor Necrosis Factor Alpha Biologic Treatment: What Now?

Thursday, January 18, 2024 - 4:00 AM

During the COVID-19 pandemic, anti-SARS-CoV-2 vaccines were quickly developed and administered to the population worldwide. As is expected with new vaccine products, adverse reactions following immunization have been reported, namely, the development

Novel antioxidant protein target therapy to counter the prevalence and severity of SARS-CoV-2

Thursday, January 18, 2024 - 4:00 AM

CONCLUSION: Innate antioxidant proteins like sirtuin and sestrin play a vital role in enhancing immunity. Herbal products and holistic approaches can also be alternative solutions for everyday life to boost the immune system by improving the redox

Noninvasive Ventilation Before Intubation and Mortality in Patients Receiving Extracorporeal Membrane Oxygenation for COVID-19: An Analysis of the Extracorporeal Life Support Organization Registry

Thursday, January 18, 2024 - 4:00 AM

Bilevel-positive airway pressure (BiPAP) is a noninvasive respiratory support modality which reduces effort in patients with respiratory failure. However, it may increase tidal ventilation and transpulmonary pressure, potentially aggravating lung

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial

Thursday, January 18, 2024 - 4:00 AM

BACKGROUND: In patients undergoing resection for pancreatic cancer, adjuvant modified fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) improves overall survival compared with alternative chemotherapy regimens. We aimed to compare

Novel engineered recombinant ACE2 reduces SARS-CoV-2-induced COVID-19 without cardiotoxic side effects

Thursday, January 18, 2024 - 4:00 AM

No abstract

Novel Strategy to Assess the Neurotoxicity of Organic Solvents Such as Glycol Ethers: Protocol for Combining In Vitro and In Silico Methods With Human-Controlled Exposure Experiments

Thursday, January 18, 2024 - 4:00 AM

CONCLUSIONS: This study will be of great interest to regulatory agencies and chemical industries needing and seeking novel solutions to develop human chemical risk assessments. It will contribute to protecting human health from the deleterious

Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models

Thursday, January 18, 2024 - 4:00 AM

A safe and effective vaccine with long-term protection against SARS-CoV-2 variants of concern (VOCs) is a global health priority. Here, we develop lipid nanoparticles (LNPs) to provide safe and effective delivery of plasmid DNA (pDNA) and show

Norwegian "dugnad" as a rhetorical device in public health communication during the COVID-19 pandemic. A qualitative study from immigrant's perspectives

Thursday, January 18, 2024 - 4:00 AM

CONCLUSION: Health communication during pandemics is crucial for maximizing compliance and gaining control of disease spread. In multicultural societies, governments and authorities should be aware of the linguistic and cultural barriers to public

National trends in sleep sufficiency and sleep time among adolescents, including the late-COVID-19 pandemic, 2009-2022: A nationally representative serial study in South Korea

Wednesday, January 17, 2024 - 4:00 AM

No abstract

New onset or recurrence of uveitis following COVID-19 infection

Wednesday, January 17, 2024 - 4:00 AM

CONCLUSION: Our observational study highlights the potential for new onset or recurrence of uveitis following COVID-19 infection.